C07D 237/22
Nitrogen and oxygen atoms
C07D237/22 (Nitrogen and oxygen atoms) appears on 155 US grants and 128 published applications in this corpus.
Search patents in C07D- Granted patents
- 155
- Published applications
- 128
- Assignees
- 108
- Inventors
- 720
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 4 | 0 |
| 1981 | 4 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 4 | 0 |
| 1985 | 2 | 0 |
| 1986 | 4 | 0 |
| 1987 | 3 | 0 |
| 1988 | 2 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 4 | 0 |
| 1992 | 5 | 0 |
| 1993 | 3 | 0 |
| 1994 | 4 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 3 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 3 | 2 |
| 2002 | 3 | 1 |
| 2003 | 5 | 6 |
| 2004 | 4 | 9 |
| 2005 | 5 | 9 |
| 2006 | 3 | 8 |
| 2007 | 3 | 5 |
| 2008 | 5 | 4 |
| 2009 | 6 | 4 |
| 2010 | 5 | 5 |
| 2011 | 2 | 6 |
| 2012 | 4 | 3 |
| 2013 | 7 | 8 |
| 2014 | 0 | 5 |
| 2015 | 8 | 4 |
| 2016 | 5 | 5 |
| 2017 | 6 | 7 |
| 2018 | 5 | 4 |
| 2019 | 4 | 2 |
| 2020 | 3 | 4 |
| 2021 | 3 | 1 |
| 2022 | 1 | 8 |
| 2023 | 1 | 9 |
| 2024 | 0 | 4 |
| 2025 | 3 | 2 |
| 2026 | 4 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents22 Sep 2026US 12,740,943 B2ModernaTX, Inc.
- Fatty acid amide hydrolase (FAAH) cleavable prodrugs of thyromimetics and combination with peripherally restricted FAAH inhibitors26 May 2026US 12,637,413 B2Autobahn Therapeutics, Inc.
- Inhibitors of SARM17 Apr 2026US 12,595,252 B2Disarm Therapeutics, Inc.
- Thyromimetics20 Jan 2026US 12,528,761 B2Autobahn Therapeutics, Inc.
- Pyridazinones and methods of use thereof7 Oct 2025US 12,435,078 B2Gfb (Abc), LLC
- Pyridazinones and methods of use thereof2 Jul 2026US 2026/0184708 A1Gfb (Abc), LLC
- Inhibitors of Dihydroceramide Desaturase for Treating Disease12 Mar 2026US 2026/0070884 A1Centaurus Therapeutics
- Pyridazinone compounds which modulate mutant proteins for treating respiratory diseases26 Feb 2026US 2026/0055065 A1The Hospital for Sick Children
- Pyridazinone compound and preparation method therefor, pharmaceutical composition thereof, and application thereof13 Nov 2025US 2025/0346579 A1China Pharmaceutical University
- Pesticidally active pyridazinone compounds6 Feb 2025US 2025/0042875 A1Syngenta Crop Protection AG
Most cited
By later US patents
- 5-heteroarylamino-6-oxy-substituted 3(2H)-pyridazinones48US 5,314,883 ANissan Chemical Industries, Ltd. · 1994
- Heteroaromatic glucokinase activators47US 6,320,050 B1Hoffmann-La Roche Inc. · 2001
- Method for inhibition of HIV related viruses44US 5,593,993 AMedivir AB · 1997
- Heteroaromatic glucokinase activators40US 6,610,846 B1Hoffman-La Roche Inc. · 2003
- Urea derivatives38US 6,528,543 B1Hoffman-La Roche Inc. · 2003